Glycomine Closes $68 Million Series B To Advance Into Clinical Trials A Novel Treatment For Pmm2-Cdg, A Rare Glycosylation Disease
Amount Raised
$68 Million
Round Type
Series B
San FranciscoBiotechnologyDescription
Glycomine, Inc., a biotechnology company focused on developing new therapies for orphan diseases, today announced that it has closed a $68 million Series B financing. The proceeds of the financing will be used to advance Glycomine’s lead drug candidate, GLM101, through initial clinical trials in patients. GLM101 is a novel substrate replacement therapy in development to treat phosphomannomutase 2-congenital disorder of glycosylation (PMM2-CDG), a rare disease representing a critical unmet medical need.
Quick answer
Glycomine, Inc. raised $68 Million in a Series B round, dated June 23, 2021. Glycomine, Inc. is based in San Francisco, California, United States.
- How much did Glycomine, Inc. raise?
- Glycomine, Inc. raised $68 Million in a Series B round on June 23, 2021.
- What does Glycomine, Inc. do?
- Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist.
- Where is Glycomine, Inc. based and how big is it?
- Glycomine, Inc. is based in San Francisco, California, United States.
- Who are the decision-makers at Glycomine, Inc?
- Fundz holds 1 contact at Glycomine, Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Glycomine, Inc. that raised within 45 days of this round, from Fundz verified event records.
- CytoImmune Therapeutics, Inc. raised $37M on August 6, 2021.
- Lanier Biotherapeutics raised $805K (Seed) on August 6, 2021.
- Singletto raised $50K on August 6, 2021.
- CHONEX raised $5.8M on August 6, 2021.
- Reimagine Care raised $5.3M on August 6, 2021.
- Unravel Biosciences, Inc. raised $500K (Seed) on August 6, 2021.
Who to call at Glycomine, Inc., and when
A new round usually means Glycomine, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Glycomine, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Glycomine, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Glycomine, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Glycomine, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansGlycomine, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.